The expression and mutation profiles of IFNG, KEAP1, and PHKG2 may serve as indicators of the tumor mutational burden (TMB) in OV, indicating their potential utility as predictive biomarkers for tumor response and prognosis. This evidence concerns the gene PHKG2 and neoplasm.